Menu

Ian A. Nussbaum

Partner

+1 212 479 6781
inussbaum@cooley.com

Ian focuses on mergers, acquisitions, divestitures, joint ventures, shareholder activism, corporate governance, takeover defense strategies and related matters. He has advised a range of public and private companies and investors across multiple industries, including technology, life sciences, financial institutions, consumer, gaming and leisure and industrials.

Download full bio

Experience

  • TiVo and Xperi to Combine in $3 Billion All-Stock Merger 

  • Instructure Sells to Thoma Bravo for $2 Billion 

  • Tableau Enters Agreement to Sell to Salesforce for $15.7 Billion 

  • Dova Pharmaceuticals Sells to Sobi for $915 Million 

  • Telaria and Rubicon to Combine in All-Stock Transaction 

  • View all

Practices & Industries
Education

  • University of Pennsylvania Law School
    JD, 2012, magna cum laude; Samuel L. Gerstley Award (highest marks in corporate law classes); Senior Editor, University of Pennsylvania Law Review

  • Columbia University
    BA, 2007, magna cum laude

Media & Insight

Recent Blog Postings

Cooley’s 2019 Tech M&A Year in Review

Cooley's 2019 Life Sciences M&A Year in Review

Taking a Play out of the Financial Acquirer’s Playbook

Use of Earn-Outs to “Bridge” the Valuation Gap

Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks

Contact

+1 212 479 6781 office
inussbaum@cooley.com

55 Hudson Yards
New York, NY 10001-2157

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.